In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including:
- Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF
- Differences in adverse effect profiles between 4 PrEP options
- Potential for HIV resistance
- Requirements for compliance and monitoring
- Evidence in populations with various acquisition behaviors
- Drug interaction implications
Faculty:
Jona Tanguay, MMSc, PA-C, AAHIVS
Health Care Provider and HIV Specialist
Whitman-Walker Health
Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality
Clinical Instructor, Yale University School of Nursing
Washington, DC
Link to full program: https://bit.ly/41WF54o
